[Breast cancer stem cell research utilizing clinical specimens]

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Context:

• Cancer stem cells (CSCs) are implicated in solid tumor progression and metastasis.
• The study of CSCs is vital for understanding cancer recurrence and treatment resistance.
• Human breast cancer research has significantly advanced since the identification of CSCs in 2003.

Purpose:

• To review the current state of human breast cancer stem cell research.
• To highlight the importance of clinical specimens in CSC studies.
• To discuss the utility of xenograft models in analyzing CSCs and metastasis.

Summary:

• The existence of cancer stem cells in solid tumors was first reported in 2003 using human breast cancer analyses.
• Clinical specimens are essential for advancing human cancer stem cell research, enabling identification of regulatory microRNAs.
• Human breast cancer xenografts serve as valuable models for studying cancer stem cells and metastasis, impacting patient survival.

Impact:

• Advances in understanding breast cancer stem cells can lead to more targeted therapies.
• Improved models for studying CSCs and metastasis can enhance prediction of patient outcomes.
• Research utilizing clinical specimens provides direct insights into human breast cancer biology.